secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001214659-24-005032
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro amends warrant and preferred stock designations to ensure equity classification
--------------------------------------------------------------------------------

- Entered warrant amendment with Ault Lending LLC to remove language that could prevent equity classification.
- Filed Certificate of Amendment to delete liquidation preference sections from Series B Preferred designations.
- Both amendments effective March 21, 2024; no other changes to terms.
- Aims to align accounting treatment; does not affect holders' economic rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465924005032/0001214659-24-005032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465924005032/o3222418k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-24-005032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer